Physician profile
Cornell Terrell Cummings
NPI 1457793960
$2,160.42
in general payments reported to CMS, 2019-2025
12 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $112 · 2021: $75.44 · 2022: $227 · 2023: $215 · 2024: $301 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $306.85 | 2025 | Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $249.35 | 2022-2025 | |
| Novo Nordisk INC | $236.13 | 2024-2025 | Wegovy, Ozempic |
| Pfizer INC. | $214.68 | 2023 | |
| Coloplast Corp | $178.84 | 2024 | |
| Sage Therapeutics, LLC | $178.24 | 2021-2022 | |
| Boston Scientific Corporation | $172.45 | 2025 | Wavewriter Alpha Prime 16 |
| Spr Therapeutics, INC | $141.49 | 2025 | Sprint Pns System |
| Pacira Pharmaceuticals Incorporated | $125.00 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $125.00 | 2025 | Austedo Xr |
| Kyowa Kirin, INC. | $120.20 | 2025 | |
| Abbvie INC. | $112.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cornell Cummings listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.